Moderna Disables Comments On X Post Announcing New Covid Shot Amid Backlash

zerohedge.com/markets/moderna-disables-comments-x-post-announcing-new-covid-shot-amid-backlash

Moderna Disables Comments On X Post Announcing New Covid Shot Amid Backlash

Moderna shares rose in premarket trading after the company announced FDA approval of its new lower-dose Covid-19 vaccine, mNEXSPIKE, for adults aged 65 and older, as well as individuals 12–64 with underlying…

This story appeared on zerohedge.com, 2025-06-02 12:50:00.
The Entire Business World on a Single Page. Free to Use →